• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性骨髓增生异常综合征的预后因素:107例病例的多变量分析

Prognostic factors in chronic myelodysplastic syndromes: a multivariate analysis in 107 cases.

作者信息

García S, Sanz M A, Amigo V, Colomina P, Carrera M D, Lorenzo J I, Sanz G F

机构信息

Sección de Hematología Clínica, Hospital La Fe, Valencia, Spain.

出版信息

Am J Hematol. 1988 Mar;27(3):163-8. doi: 10.1002/ajh.2830270303.

DOI:10.1002/ajh.2830270303
PMID:3348201
Abstract

A retrospective multivariate analysis of 37 clinical, biochemical, and hematological data was performed in 107 cases of primary myelodysplastic syndromes (MDS) in order to recognize their prognostic significance. The most important individual variables, isolated in a previous univariate analysis, were placed in a multiple regression modeling procedure to identify major significant prognostic factors. Multivariate analysis tends to identify prognostic variables containing significant independent predictive information. Characteristics were examined on both continuous and binary bases. The FAB classification was the first parameter entered in regression equations on both models, followed by platelet count, hemoglobin level, and circulating erythroblasts in the binary model, and by hemoglobin level, systemic symptoms, platelet count, age, and dyserythropoiesis in the continuous model. Our analysis confirms FAB classification as the main prognostic factor in MDS, supports the previously noted predictive value of platelet count, hemoglobin level, and age, and recognises the importance of circulating erythroblasts, systemic symptoms, and dyserythropoiesis as prognostic characteristics in MDS.

摘要

为了认识其预后意义,对107例原发性骨髓增生异常综合征(MDS)患者的37项临床、生化和血液学数据进行了回顾性多变量分析。在先前的单变量分析中分离出的最重要的个体变量,被纳入多元回归建模程序,以确定主要的显著预后因素。多变量分析倾向于识别包含显著独立预测信息的预后变量。对连续和二元特征均进行了检查。FAB分类是两个模型回归方程中输入的第一个参数,在二元模型中其次是血小板计数、血红蛋白水平和循环成红细胞,在连续模型中其次是血红蛋白水平、全身症状、血小板计数、年龄和红细胞生成异常。我们的分析证实FAB分类是MDS的主要预后因素,支持先前指出的血小板计数、血红蛋白水平和年龄的预测价值,并认识到循环成红细胞、全身症状和红细胞生成异常作为MDS预后特征的重要性。

相似文献

1
Prognostic factors in chronic myelodysplastic syndromes: a multivariate analysis in 107 cases.慢性骨髓增生异常综合征的预后因素:107例病例的多变量分析
Am J Hematol. 1988 Mar;27(3):163-8. doi: 10.1002/ajh.2830270303.
2
Prognostic factors in myelodysplasic syndromes: a multivariante analysis in 138 patients.骨髓增生异常综合征的预后因素:138例患者的多变量分析
Arch Invest Med (Mex). 1989 Jan-Mar;20(1):45-52.
3
Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors.骨髓增生异常综合征的骨髓活检:形态学特征及其对预后因素研究的贡献
Br J Haematol. 1990 May;75(1):26-33. doi: 10.1111/j.1365-2141.1990.tb02612.x.
4
Myelodysplastic syndromes. A multiparametric study of prognostic factors in 336 patients.骨髓增生异常综合征。336例患者预后因素的多参数研究。
Cancer. 1987 Dec 15;60(12):3029-32. doi: 10.1002/1097-0142(19871215)60:12<3029::aid-cncr2820601229>3.0.co;2-4.
5
Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.细胞遗传学分析在初治骨髓增生异常综合征中具有强大的独立预后价值,可纳入一种新的评分系统:408例报告
Leukemia. 1993 Sep;7(9):1315-23.
6
[Myelodysplastic syndromes: preleukemic syndromes].[骨髓增生异常综合征:白血病前期综合征]
Rev Med Liege. 1998 Jun;53(6):357-62.
7
Detection of risk groups in myelodysplastic syndromes. A multicenter study.骨髓增生异常综合征风险组的检测。一项多中心研究。
Haematologica. 2002 Jan;87(1):9-16.
8
The classification of MDS: from FAB to WHO and beyond.MDS 的分类:从 FAB 到 WHO 及其他。
Leuk Res. 2012 Dec;36(12):1453-8. doi: 10.1016/j.leukres.2012.08.008. Epub 2012 Aug 30.
9
International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.国际骨髓增生异常综合征风险分析研讨会(IMRAW)/国际预后评分系统(IPSS)重新分析:血细胞减少对骨髓增生异常综合征临床结局的影响
Am J Hematol. 2008 Oct;83(10):765-70. doi: 10.1002/ajh.21249.
10
Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.原发性骨髓增生异常综合征:235例患者预后因素分析及改进评分系统的建议
Leukemia. 1992 Jan;6(1):52-9.

引用本文的文献

1
Models of Prognostication in Chronic Myelomonocytic Leukemia.慢性粒单核细胞白血病的预后模型
Curr Hematol Malig Rep. 2017 Dec;12(6):513-521. doi: 10.1007/s11899-017-0416-8.
2
Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.生长因子在低危骨髓增生异常综合征细胞凋亡调控中的作用
Med Oncol. 2006;23(1):37-49. doi: 10.1385/MO:23:1:137.
3
Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes.骨髓增生异常综合征中骨髓活检组织学发现的预后相关性。
Ann Hematol. 1993 Feb;66(2):85-91. doi: 10.1007/BF01695890.
4
FAB classification of myelodysplastic syndromes: merits and controversies.骨髓增生异常综合征的FAB分类:优点与争议
Ann Hematol. 1995 Jul;71(1):3-11. doi: 10.1007/BF01696227.
5
Correlations between cytogenetics and morphology in myelodysplastic syndromes.骨髓增生异常综合征的细胞遗传学与形态学之间的相关性
Blut. 1990 Apr;60(4):223-7. doi: 10.1007/BF01728788.
6
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study.低剂量阿糖胞苷治疗骨髓增生异常综合征的评估:一项III期组间研究。
Ann Hematol. 1992 Oct;65(4):162-8. doi: 10.1007/BF01703109.